Detalles de la búsqueda
1.
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
BMC Cancer
; 24(1): 370, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528445
2.
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.
Br J Haematol
; 202(3): 498-503, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37303189
3.
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy.
Br J Haematol
; 196(2): 368-373, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34490623
4.
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial.
BMC Cancer
; 22(1): 1174, 2022 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36376888
5.
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
Blood
; 130(17): 1889-1897, 2017 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29074595
6.
The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease.
BMC Cancer
; 19(1): 471, 2019 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31109313
7.
The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib.
Blood
; 134(23): 2107-2111, 2019 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578205
8.
Trial re-investment to build better research for better impact.
Lancet
; 394(10199): 635-636, 2019 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31448733
9.
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.
Nat Commun
; 14(1): 7725, 2023 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001082
10.
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
J Clin Oncol
; 41(19): 3534-3544, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126762
11.
Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapy.
EJHaem
; 3(3): 794-803, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36051087
12.
Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers.
Contemp Clin Trials Commun
; 14: 100361, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31011660
Resultados
1 -
12
de 12
1
Próxima >
>>